The purpose of this guide is to provide resources related to Coronavirus Disease 2019 (COVID-19). NOTE: This Guide supplements but does not supersede the COVID-19 information provided by the UT Southwestern Emergency Operations Center.
NIH - Coronavirus Disease 2019 (COVID-19) Treatment GuidelinesThese Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information become available.
The COVID-19 pandemic has drawn attention to the human host genes associated with SARS-CoV-2 entry and to the elements that regulate expression of these genes. At NCBI, we have prioritized curation of experimentally validated regulatory elements for these genes in the RefSeq Functional Elements project.
NCBI SARS-CoV-2 Variant Calling Pipeline and Related Data Products - Still waiting for an analysis pipeline that can uniformly process raw sequence data produced by a variety of sequencing platforms? Your wait is over! Announcing the SARS-CoV-2 Variant Calling Pipeline, which is now operational and optimized to provide support for multiple sequencing platforms including, Illumina, Oxford Nanopore, and PacBio.
The profound impact of the COVID-19 pandemic prompted the NIH Genetic Testing Registry (GTR) to expand its scope to include microbe tests. We will focus initially on molecular tests to detect the SARS-CoV-2 virus and serology tests to detect viral antigens and antibodies to the virus.